Doseology Sciences Inc. (MOOD.CN)

CAD 0.4

(8.11%)

Net Income Summary of Doseology Sciences Inc.

  • Doseology Sciences Inc.'s latest annual net income in 2023 was -339.84 Thousand CAD , up 80.92% from previous year.
  • Doseology Sciences Inc.'s latest quarterly net income in 2023 Q4 was -109.58 Thousand CAD , down -170.32% from previous quarter.
  • Doseology Sciences Inc. reported an annual net income of -1.78 Million CAD in 2022, up 8.14% from previous year.
  • Doseology Sciences Inc. reported an annual net income of -1.93 Million CAD in 2021, down -19.23% from previous year.
  • Doseology Sciences Inc. reported a quarterly net income of -40.53 Thousand CAD for 2023 Q3, up 63.69% from previous quarter.
  • Doseology Sciences Inc. reported a quarterly net income of -78.08 Thousand CAD for 2023 Q1, up 93.19% from previous quarter.

Annual Net Income Chart of Doseology Sciences Inc. (2023 - 2019)

Historical Annual Net Income of Doseology Sciences Inc. (2023 - 2019)

Year Net Income Net Income Growth
2023 -339.84 Thousand CAD 80.92%
2022 -1.78 Million CAD 8.14%
2021 -1.93 Million CAD -19.23%
2020 -1.62 Million CAD -276.84%
2019 -431.63 Thousand CAD 0.0%

Peer Net Income Comparison of Doseology Sciences Inc.

Name Net Income Net Income Difference
Algernon Pharmaceuticals Inc. -6.78 Million CAD 94.988%
Asep Medical Holdings Inc -8.22 Million CAD 95.869%
BetterLife Pharma Inc. -2.88 Million CAD 88.237%
BioVaxys Technology Corp. -7.68 Million CAD 95.579%
ChitogenX Inc. -1.55 Million CAD 78.131%
Rapid Dose Therapeutics Corp. -4.3 Million CAD 92.108%
Defence Therapeutics Inc. -13.19 Million CAD 97.424%
Entheon Biomedical Corp. -300 Thousand CAD -13.282%
Gemina Laboratories Ltd. -5.21 Million CAD 93.485%
Glow Lifetech Corp. -1.64 Million CAD 79.348%
Lexston Life Sciences Corp. -867.71 Thousand CAD 60.834%
Pharmala Biotech Holdings Inc. -779.81 Thousand CAD 56.419%
MYND Life Sciences Inc. -1.51 Million CAD 77.61%
Nova Mentis Life Science Corp. -1.22 Million CAD 72.244%
PharmaTher Holdings Ltd. -3.11 Million CAD 89.091%
PreveCeutical Medical Inc. -1.27 Million CAD 73.334%
Telescope Innovations Corp. -5.72 Million CAD 94.066%